Researchers at the State University of New York have identified distinct risks associated with the two primary treatments for early-stage prostate cancer. While radiation therapy is linked to higher mortality rates, surgical options present a greater risk of incontinence and erectile dysfunction .
A 45% higher mortality rate for radiation patients
The State University of New York study, which analyzed medical records from more than 20,000 men,found a stark difference in survival outcomes. According to the researchers, men treated with radiation therapy experienced a 45 percent higher rate of death from any cause during the five-year follow-up period. Specifically, the death rate for the radiation group was approximately 8 percent, whereas the surgical group saw a rate of 6 .5 percent.
Dr. Jeffrey Weiss, a professor of urology and the study's lead author, emphasized that these findings highlight how much treatment choice matters. While the study notes that radiation is associated with higher rates of bladder inflammation and blood in the urine, the researchers could not definitively prove that the radiation itself caused the higher mortality rates.
The 29% incontinence risk facing surgical patients
Surgical intervention, specifically a radical prostatectomy, presents a different set of debilitating side effects compared to radiotherapy. As the report states, men who opted for surgery faced a 29 percent rate of urinary incontinence, a figure significantly higher than the 6 percent reported among those treated with radiation.
Beyond urinary issues, the surgical cohort also faced substantial sexual health challenges. Approximately one-third of men who underwent the removal of the prostate gland developed erectile dysfunction . Dr. Jeffrey Weiss noted that clinicians must carefully discuss these specific risks, including infertility, to help patients weigh the potential for a cure against long-term lifestyle impacts.
The National Screening Committee's stance on over-treatment
The debate over prostate cancer management is intensified by broader concerns regarding how the disease is detected and managed. Earlier this year, the National Screening Committee rejected a proposal for a national prostate cancer screening program, citing the risks of over-diagnosis and over-treatment.
This caution aligns with other recent medical findings regarding the side effects of cancer management. For instance, the use of androgen receptor pathway inhibitors alongside radiotherapy has been linked to increased risks of obesity, diabetes, and heart problems due to lowered testosterone levels. These factors add layers of complexity to the decision-making process for the 68,000 men diagnosed with prostate cancer annually in the UK alone.
Why the cause of radiation-linked deaths remains unverified
A critical gap reamins in understanding whether the increased mortality in the radiation group is a direct result of the treatment or a byproduct of other patient factors. Because the State University of New York study was observational, it cannot establish a direct cause-and-effect relationship between radiation therapy and the 45 percent higher death rate.
Future research must address whether these mortality differences persist when looking specifically at prostate cancer-related deaths rather than all-cause mortality... Additionally, the medical community still needs to clarify how the 17 percent of Black men in the study—a group three times more likely to develop the disease—might experience these treatment outcomes differently in a clinical setting.
Comments 0